Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
James Miles
Observed names:
J. Miles,
Miles, James,
Miles, James David
Institution:
Fastbase Solutions (Spain)
Observed institutions:
Ikerbasque,
University of the Basque Country,
BioCruces Health research Institute,
Euskadiko Parke Teknologikoa,
Instituto Biofisika,
Fastbase Solutions (Spain),
Institut Bergonié,
Hospital de Cruces,
Instituto di Biofisica,
University of Bath
show all 10
ORCID:
0009-0001-9560-6026
Observed ORCID:
0009-0001-9560-6026
OpenAlex ID:
A5011820835
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts
2021
·
Michele Bortolomeazzi
, Mohamed Reda Keddar
, et al.
·
Gastroenterology
·
160
PDF
Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer
2023
·
Lissete Sánchez-Magraner
, Juan Gumuzio
, et al.
·
Journal of Clinical Oncology
·
82
PDF
High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
2020
·
Lissete Sánchez-Magraner
, James Miles
, et al.
·
Cancer Research
·
53
Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma
2017
·
James Miles
, Christopher J. Applebee
, et al.
·
BBA Clinical
·
11
PDF
Quantification of PD-1/PD-L1 Interaction between Membranes from PBMCs and Melanoma Samples Using Cell Membrane Microarray and Time-Resolved Förster Resonance Energy Transfer
2021
·
Lissete Sánchez-Magraner
, Miguel de la Fuente
, et al.
·
Analytica—A Journal of Analytical Chemistry and Chemical Analysis
·
10
PDF
Quantification of biomarker functionality predicts patient outcomes
2021
·
Banafshé Larijani
, James Miles
, et al.
·
British Journal of Cancer
·
9
PDF
Quantification of protein-protein interactions and activation dynamics: A new path to predictive biomarkers
2022
·
Banafshé Larijani
, James Miles
·
Biophysical Chemistry
·
6
PDF
The fusion of quantitative molecular proteomics and immune‐oncology : a step towards precision medicine in cancer therapeutics
2022
·
James Miles
, Stephen G. Ward
, et al.
·
FEBS Letters
·
5
PDF
Determination of Interactive States of Immune Checkpoint Regulators in Lung Metastases after Radiofrequency Ablation
2022
·
James Miles
, Isabelle Soubeyran
, et al.
·
Cancers
·
3
PDF
Immune checkpoint crosstalk: CTLA-4/CD80 engagement as a predictor of anti-PD-1/PD-L1 therapy outcome in NSCLC
2026
·
Juan Gumuzio
, James Miles
, et al.
·
Frontiers in Immunology
·
2
PDF
Simultaneous Quantification of Multiple Immune Checkpoint Interactions in Melanoma
2026
·
Cristina Cacho-Navas
, Laura Camacho
, et al.
·
Journal of Clinical Medicine
·
1
PDF
Multiplexed FRET-FLIM Profiling of Immune Checkpoint Interactions Predicts Response to Atezolizumab in Urothelial Carcinoma
2026
·
Laura Camacho
, Cristina Cacho-Navas
, et al.
·
medRxiv
PDF
120 Beyond PD-L1: unraveling the enigma of immunotherapy response in PD-L1 negative (<1%) NSCLC patients through quantification of PD-1/PD-L1 engagement in the tumour microenvironment
2024
·
Veronique Calleja
, Juan Gumuzio
, et al.
·
Journal for ImmunoTherapy of Cancer
259 (PB247): Beyond PD-L1: unraveling the enigma of immunotherapy response in PD-L1 negative (<1%) NSCLC patients through quantification of PD-1/PD-L1 engagement in the tumour microenvironment
2024
·
J. Miles
, J. Gumuzio
, et al.
·
European Journal of Cancer
Abstract A124: Beyond PD-L1: Unraveling the enigma of immunotherapy response in PD-L1 negative (<1%) NSCLC patients through quantification of PD-1/PD-L1 engagement in the tumor microenvironment
2023
·
Juan Gumuzio
, Veronique Calleja
, et al.
·
Molecular Cancer Therapeutics
222-G Beyond PD-L1: unraveling the enigma of immunotherapy response in PD-L1 negative (<1%) NSCLC patients through quantification of PD-1/PD-L1 engagement in the tumor microenvironment
2023
·
Juan Gumuzio
, Lissete Sanchez-Magraner
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Le rôle des états interactifs des régulateurs des points de contrôle immunitaires dans le cancer : déterminé par l'imagerie quantitative avancée.
2022
·
James Miles
·
theses.fr (ABES)
Immunogenomics of colorectal cancer response to immune checkpoint blockade: TCRseq
2020
·
Bortolomeazzi, Michele
, Keddar, Mohamed Reda
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Immunogenomics of colorectal cancer response to immune checkpoint blockade: Imaging Mass Cytometry
2020
·
Bortolomeazzi, Michele
, Keddar, Mohamed Reda
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Immune-checkpoint engagement as predictive biomarkers in clear cell renal cell carcinoma and melanoma
2020
·
Lissete Sánchez-Magraner
, James Miles
, et al.
·
medRxiv
PDF
Show more works
View as search
Works count:
23
Citation count:
342
H-index:
6
I10-index:
5
Year
Topic
Type
